Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Pedro López is active.

Publication


Featured researches published by Pedro López.


Antimicrobial Agents and Chemotherapy | 2005

Efficacy of Nebulized Liposomal Amphotericin B in Treatment of Experimental Pulmonary Aspergillosis

Joan Gavaldà; María-Teresa Martín; Pedro López; Xavier Gomis; José-Luís Ramírez; Dolors Rodríguez; Oscar Len; Yolanda Puigfel; Isabel Ruiz; Albert Pahissa

ABSTRACT The efficacy of therapeutic aerosolized amphotericin B (AMB) was studied in a steroid-immunosuppressed murine model of invasive pulmonary aspergillosis. Nebulized liposomal AMB can be a valid approach to the treatment of this infection, with subjects showing significantly improved survival relative to that of subjects given intravenous deoxycholate AMB, as well as lower lung weights and pulmonary glucosamine levels.


Antimicrobial Agents and Chemotherapy | 2002

Efficacy of ceftriaxone and gentamicin given once a day by using human-like pharmacokinetics in treatment of experimental staphylococcal endocarditis.

Joan Gavaldà; Pedro López; Teresa Martín; Xavier Gomis; Carlos Azuaje; Benito Almirante; Albert Pahissa

ABSTRACT We compared the efficacy of ceftriaxone combined with gentamicin, both given once a day, with that of cloxacillin given every 4 h plus gentamicin given once a day or in three daily doses (t.i.d.) for the treatment of experimental methicillin-susceptible staphylococcal endocarditis. The antibiotics were administered by using human-like (H-L) pharmacokinetics that simulated the profiles of these drugs in human serum. Animals with catheter-induced endocarditis were infected intravenously with 105 CFU of Staphylococcus aureus S5 (MICs and minimal bactericidal concentrations of cloxacillin, ceftriaxone, and gentamicin, 0.5 and 2 μg/ml, 4 and 8 μg/ml, and 0.5 and 1 μg/ml, respectively). The animals were then treated for 24 h with cloxacillin at a dose of 2 g that simulated H-L pharmacokinetics (H-L 2 g) every 4 h alone or combined with gentamicin (administered at doses of H-L 1 mg/kg of body weight every 8 h or H-L 4.5 mg/kg every 24 h) or with ceftriaxone at H-L 2 g every 24 h alone or combined with gentamicin (administered at doses of H-L 1 mg/kg every 8 h or H-L 4.5 mg/kg every 24 h). The results of therapy for experimental endocarditis due to the S5 strain showed that (i) cloxacillin alone is more effective than ceftriaxone alone in reducing the bacterial load (P < 0.01), (ii) the combination of cloxacillin or ceftriaxone with gentamicin is more effective than each of these drugs alone (P < 0.01), and (iii) Ceftriaxone H-L plus gentamicin H-L 4.5 mg/kg, both administered every 24 h, showed efficacy similar to that of the “gold standard,” cloxacillin H-L plus gentamicin H-L 1 mg/kg t.i.d. (P > 0.05). An increase in the interval of administration of gentamicin to once daily resulted in a reduction in the numbers of bacteria in the vegetations equivalent to that achieved with the recommended regimen of cloxacillin plus gentamicin t.i.d. in the treatment of experimental endocarditis due to methicillin-susceptible S. aureus. Ceftriaxone plus gentamicin, both administered once a day, may be useful for home-based therapy for selected cases of staphylococcal endocarditis.


Antimicrobial Agents and Chemotherapy | 1999

Efficacy of Ampicillin plus Ceftriaxone in Treatment of Experimental Endocarditis Due to Enterococcus faecalis Strains Highly Resistant to Aminoglycosides

Joan Gavaldà; Carmen Torres; Carmen Tenorio; Pedro López; Myriam Zaragoza; Josep A. Capdevila; Benito Almirante; Fernanda Ruiz; Nuria Borrell; Xavier Gomis; Carles Pigrau; Fernando Baquero; Albert Pahissa


Clinical Microbiology and Infection | 2001

Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique

Josep A. Capdevila; Joan Gavaldà; J. Fortea; Pedro López; María-Teresa Martín; Xavier Gomis; Albert Pahissa


Clinical Microbiology and Infection | 2005

Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis

Joan Gavaldà; T. Martín; Pedro López; Xavier Gomis; Dolors Rodríguez; Oscar Len; Y. Puigfel; Isabel Ruiz; Albert Pahissa


Journal of Antimicrobial Chemotherapy | 2003

Efficacy of high doses of liposomal amphotericin B in the treatment of experimental aspergillosis

María Teresa Martín; Joan Gavaldà; Pedro López; Xavier Gomis; Dolors Rodríguez; Oscar Len; Queralt Jordano; Isabel Ruiz; Marta Rosal; Benito Almirante; Albert Pahissa


Papers. Revista de Sociologia | 1998

La segmentación laboral: hacia una tipología del ámbito productivo

Pedro López; Faustino Miguélez; Andreu Lope; Xavier Coller


Questiió: Quaderns d'Estadística, Sistemes, Informatica i Investigació Operativa | 1999

La articulación entre lo cuantitativo y lo cualitativo: de las grandes encuestas a la recogida de datos intensiva

Vicent Borràs Català; Pedro López; Carlos Lozares Colina


Papers. Revista de Sociologia | 2007

La conciliación entre las exigencias del ámbito productivo y las condiciones sociofamiliares : estudio de caso de una empresa

Pedro López; Carlos Lozares Colina


Revista catalana de sociología | 2000

Aplicació de les xarxes socials a l'anàlisi de la formació invisible en l'empresa

Joan Miquel Verd Pericàs; Joel Martí Olivé; Carlos Lozares Colina; Pedro López

Collaboration


Dive into the Pedro López's collaboration.

Top Co-Authors

Avatar

Albert Pahissa

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Joan Gavaldà

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Xavier Gomis

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Benito Almirante

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Dolors Rodríguez

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Isabel Ruiz

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Oscar Len

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Carlos Lozares Colina

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Fausto Miguélez

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Josep A. Capdevila

Autonomous University of Barcelona

View shared research outputs
Researchain Logo
Decentralizing Knowledge